Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 25, 2006

Millipore to Develop and Market SCS’ Media for Growth of HESC

  • Millipore will develop and market Stem Cell Sciences’ (SCS) serum-free media for the growth of human embryonic stem cells (HESC), according to an exclusive license deal between the two firms.

    “We chose SCS because their media worked extremely well in growing hESCs in a variety of different stem cell lines and conditions and they had the most advanced development of serum-free media,” explains Dominique Baly, president of Millipore’s bioscience division.

    Under the terms of the agreement, Millipore will manufacture, market, and sell the new media under the brand name HEScGRO Embryonic Stem Cell Medium. SCS will receive royalties from all future sales of HEScGRO Embryonic Stem Cell Medium.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »